Seeking Alpha

OSI Pharmaceuticals Inc. (OSIP)

()

News & PR
Market Currents

Buzz
Twitter: OSIP

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

This Week's Failed Trials, Missed Targets in Biotech

Dec 20 • The Burrill Report • 1 Comment
Lilly to Benefit from OSI Rejection

Dec 17 • EP Vantage • Comment!
China Biotech Week in Review: International Initiatives

Oct 25 • ChinaBio Today • Comment!
Wall Street Breakfast: Must-Know News

Oct 22 • SA Editor Eli Hoffmann • 11 Comments
Simcere to Develop OSI Pharmaceutical Cancer Drug in China

Oct 21 • ChinaBio Today • 1 Comment
Galleon's Top 10 Holdings

Oct 20 • TraderMark • 4 Comments
Galleon Group's 50 Largest Holdings

Oct 18 • AlphaClone • 10 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Sep 20 • Justin M. Hall • 3 Comments
Friday's Options Recap

Sep 11 • Frederic Ruffy • 1 Comment
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Sep 11 • Justin M. Hall • 23 Comments
Who Will Buy Spectrum Pharmacueticals?

Aug 6 • Mark Cifra • 2 Comments
Wall Street Breakfast: Must-Know News

Jul 23 • SA Editor Rachael Granby • 18 Comments
OSI: Tarceva Approved as Maintenance Treatment for Lung Cancer

Jul 14 • Prohost Biotech • Comment!
FDA Calendar Updates: BioMarin, OSI, Roche, Abraxis, Johnson & Johnson

Jul 14 • Mike Havrilla • Comment!
Financial Stocks Set the Stage for Earnings Reports

Jul 14 • J Clinton Hill • 2 Comments
Closing Update for Monday, June 13

Jul 13 • Midnight Trader • 1 Comment
OSI Pharmaceutical Gets a Boost from Cancer Drug

Jul 13 • optionMONSTER • Comment!
Seven Laggard Biotech Trades

Jun 18 • Mike Havrilla • Comment!
Alimta: The 'Winner' of ASCO 2009

Jun 16 • Ohad Hammer • 1 Comment
Galleon Bets Heavily on the S&P 500

Jun 9 • Market Folly • Comment!
Wednesday Options Recap

Jun 3 • Frederic Ruffy • 1 Comment
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO

Jun 1 • Mike Havrilla • 2 Comments
Big Pharma's Pheeding Phrenzy

May 28 • Mike Huckman • Comment!
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly

May 27 • Mark Cifra • 4 Comments
Tuesday's Options Recap

May 19 • Frederic Ruffy • Comment!
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly

Apr 2 • Mark Cifra • 5 Comments
FDA and Clinical Trial Calendars: Favorable Vote for Sanofi's Multaq

Mar 22 • Mike Havrilla • Comment!
Where Might Genentech Investors Redeploy $47B?

Mar 16 • Michael Becker • 2 Comments
Market Goes Down, Biotech and Healthcare Lead the Way

Feb 27 • MyHappyTrading.com • 6 Comments
Are Large Cap Stocks More Effective than Small Caps?

Feb 23 • Value Expectations • Comment!
Wall Street Breakfast: Must-Know News

Feb 20 • SA Editor Rachael Granby • 8 Comments
Biotechs Lead Markets Higher

Feb 5 • MyHappyTrading.com • 2 Comments
Can Steve Jobs's Case Help Propel Biopharma?

Jan 16 • Mike Huckman • 3 Comments
9 Possible Pharma Deals for 2009

Jan 8 • Zacks.com • 7 Comments
Fast Money Recap - Bullish on Biotech (1/5/09)

Jan 6 • SA Editor Miriam Metzinger • Comment!
AstraZeneca Trials Provide Zest and Zeal for OSI Pharmaceuticals

Nov 20, 2008 • Mike Huckman • Comment!
A Biotech Bloom in July

Jul 28, 2008 • Option Dragon • 10 Comments
Will Yahoo Settle? Fast Money Recap (5/28/08)

May 29, 2008 • SA Editor Miriam Metzinger • 8 Comments
ASCO: Whose Presentations Look the Most Promising?

May 27, 2008 • Dan Rosenblum • 2 Comments
Oncology Conference Countdown: What Will Pharma and Biotech Companies Report?

May 16, 2008 • Mike Huckman • 4 Comments
Three Game-Changers For Big Pharma

May 15, 2008 • Michael Steinberg • 2 Comments

OSI Pharmaceuticals Inc. (OSIP)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers